06 April 2021: Original Paper
Intensified Endoscopic Evaluation for Biliary Complications After Orthotopic Liver Transplantation
Tim R. Glowka 1ABCDEF , Caroline Karlstetter 1BCF , Tobias J. Weismüller 2BCD , Tim O. Vilz 1CD* , Christian P. Strassburg 2CD , Jörg C. Kalff 1CD , Steffen Manekeller 1ACDEFDOI: 10.12659/AOT.928907
Ann Transplant 2021; 26:e928907
Table 4 Risk factors for one-year mortality.
| Alive | Deceased | P | |
|---|---|---|---|
| n=89 | n=13 | ||
| Cause of cirrhosis: viral hepatitis | 28 (31%) | 0 (0%) | 0.017 |
| Pre-existing cardial comorbidity | 14 (16%) | 6 (46%) | 0.019 |
| Redo transplantation | 7 (8%) | 4 (31%) | 0.032 |
| Donor organ weight (g) | 1655±392 | 1357±261 | 0.002 |
| Bilirubin trough (mg/dl) first 30 days | 0.86 (0.54–1.29) | 1.07 (0.77–4.07) | 0.043 |
| ICU stay | 5 (3–13) | 26 (9–182) | 0.003 |
| Postoperative hemorrhage | 13 (15%) | 6 (46%) | 0.014 |
| Biliary complications | 34 (38%) | 9 (69%) | 0.034 |
| Primary nonfunction | 2 (2%) | 3 (23%) | 0.014 |
| Repeated surgery | 24 (27%) | 8 (62%) | 0.022 |
| Data are expressed as number (%), mean±standard deviation or median (interquartile range). | |||